GENEVA - The risk-benefit balance for the AstraZeneca COVID-19 vaccine is "still largely positive", the World Health Organization said Tuesday after fresh claims about links to blood clots.
"There is no link for the moment between the vaccine and thrombotic events with thrombocytopenia," Rogerio Pinto de Sa Gaspar, the WHO's director for regulation and pre-qualification, told a press conference. The AstraZeneca jabs produced in South Korea and India, plus the Pfizer-BioNTech vaccine and that of Johnson and Johnson, are the only ones to have received WHO authorization so far in the COVID-19 pandemic.On March 18, after several countries suspended the use of the AstraZeneca jab, the EMA stressed that the benefits of using it outweighed the risks and it should remain in use.
"The question with any pharmaceutical or vaccine is whether the risk of taking it is greater or less than the risk of the disease it is meant to prevent or treat," he said at the time.
Source: Healthcare Press (healthcarepress.net)
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ABSCBNNews - 🏆 5. / 83 Read more »
Source: manilabulletin - 🏆 25. / 51 Read more »
Source: ABSCBNNews - 🏆 5. / 83 Read more »
Source: ABSCBNNews - 🏆 5. / 83 Read more »
Source: inquirerdotnet - 🏆 3. / 86 Read more »